Get the Stockscreener App
0.212
1.00%
0.0021
After Hours:
.22
0.008
+3.77%
Theriva Biologics Inc Stock (TOVX) Forecast
The Theriva Biologics Inc (TOVX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $79.46, representing a +37,382% increase from the current price of $0.212. The highest analyst price target is $137.35, and the lowest is $21.57.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TOVX Price Target
Average 105.43
(+49,631% Upside)
Is Theriva Biologics Inc (TOVX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.28 | Neutral |
| STOCH(9,6) | 18.85 | Buy |
| STOCHRSI(14) | 31.66 | Neutral |
| MACD(12,26) | -0.00535 | Sell |
| ADX(14) | 14.18 | Neutral |
| William %R | -93.55 | Buy |
| CCI(14) | -92.17 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2207
Sell
|
0.2186
Sell
|
| MA20 |
0.2232
Sell
|
0.2231
Sell
|
| MA50 |
0.2321
Sell
|
0.2307
Sell
|
| MA100 |
0.2414
Sell
|
0.2397
Sell
|
| MA200 |
0.2409
Sell
|
0.2671
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TOVX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on TOVX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.28 indicates that TOVX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.85 indicates that TOVX is oversold. This indicates that TOVX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.66 indicates that TOVX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.18 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -92.17 indicates that TOVX is still oversold but not to an extreme extent.
Long-term TOVX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Theriva Biologics Inc financial reports and earnings history, Theriva Biologics Inc (TOVX) stock could reach $5.928 by 2030, $935.57 by 2040 and $1,665.57 by 2050. See the projected annual prices until 2050 of the Theriva Biologics Inc stock below:
- Theriva Biologics Inc (TOVX) is expected to reach an average price of $374.98 in 2035, with a high prediction of $391.89 and a low estimate of $375.04. This indicates an $176.78K% rise from the last recorded price of $0.212.
- Theriva Biologics Inc (TOVX) stock is projected to chart a bullish course in 2040, with an average price target of $887.07, representing an $418.33K% surge from its current level. The forecast ranges from a conservative $902.63 to a sky-high $935.57.
- Our analysts predict Theriva Biologics Inc (TOVX) to jump 328.72K% by 2045, soaring from $697.10 to an average price of $697.10, potentially reaching $732.76. While $697.10 is the low estimate, the potential upside is significant.
- Theriva Biologics Inc (TOVX) stock is expected to climb by 2050, reaching an average of $1,646.34, a $776.47K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,665.57 and $1,667.15, respectively, highlighting the market's uncertainty.
Theriva Biologics Inc Stock (TOVX) Year by Year Forecast
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2026
The predicted value for Theriva Biologics Inc (TOVX) in 2026 is set at an average of $68.76. Estimates vary from a peak of $137.35 to a trough of $0.1628, indicating an +32,332% surge from the present price of $0.212.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $26.26 | $21.57 | $137.35 | +12,287% |
| December, 2026 | $18.02 | $10.56 | $60.41 | +8,402% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Theriva Biologics Inc (TOVX) is $105.43, with a high forecast of $202.95 and a low forecast of $7.9049. This indicates an +49,631% increase from the last price of $0.212.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $92.85 | $11.01 | $108.48 | +43,698% |
| February, 2027 | $79.93 | $50.44 | $107.71 | +37,601% |
| March, 2027 | $58.12 | $29.90 | $202.95 | +27,313% |
| April, 2027 | $35.63 | $9.2961 | $67.10 | +16,706% |
| May, 2027 | $52.18 | $7.9049 | $93.98 | +24,514% |
| June, 2027 | $54.86 | $51.38 | $46.29 | +25,776% |
| July, 2027 | $23.47 | $34.09 | $48.56 | +10,970% |
| August, 2027 | $99.15 | $61.79 | $49.87 | +46,671% |
| September, 2027 | $179.40 | $179.62 | $180.52 | +84,524% |
| October, 2027 | $175.74 | $175.76 | $178.75 | +82,797% |
| November, 2027 | $167.82 | $168.07 | $174.24 | +79,062% |
| December, 2027 | $162.59 | $162.63 | $166.26 | +76,594% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2028
In 2028, Theriva Biologics Inc (TOVX) is projected to reach an average price of $123.63, with a high projection of $161.03 and a low estimate of $86.22. This indicates an +58,214% rise from the last price of $0.212.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $154.83 | $154.84 | $161.03 | +72,935% |
| February, 2028 | $149.20 | $149.23 | $153.15 | +70,278% |
| March, 2028 | $143.08 | $143.16 | $147.44 | +67,391% |
| April, 2028 | $137.43 | $137.47 | $141.53 | +64,726% |
| May, 2028 | $129.71 | $129.85 | $135.93 | +61,084% |
| June, 2028 | $124.62 | $124.68 | $128.21 | +58,684% |
| July, 2028 | $117.31 | $117.31 | $123.12 | +55,235% |
| August, 2028 | $111.29 | $111.37 | $115.79 | +52,395% |
| September, 2028 | $105.41 | $105.43 | $109.79 | +49,620% |
| October, 2028 | $98.00 | $98.02 | $103.91 | +46,125% |
| November, 2028 | $92.05 | $92.06 | $96.48 | +43,317% |
| December, 2028 | $86.15 | $86.22 | $90.53 | +40,539% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2029
The 2029 price forecast for Theriva Biologics Inc Stock (TOVX) is $46.04 on average, with a high prediction of $84.66 and a low estimate of $7.4285. This represents an +21,618% increase from the previous price of $0.212.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $78.79 | $78.86 | $84.66 | +37,065% |
| February, 2029 | $72.92 | $72.93 | $77.31 | +34,295% |
| March, 2029 | $66.96 | $66.97 | $71.39 | +31,486% |
| April, 2029 | $59.54 | $59.55 | $65.46 | +27,985% |
| May, 2029 | $53.58 | $53.59 | $58.03 | +25,171% |
| June, 2029 | $47.59 | $47.59 | $52.00 | +22,347% |
| July, 2029 | $40.02 | $40.04 | $46.06 | +18,780% |
| August, 2029 | $34.17 | $34.19 | $38.55 | +16,019% |
| September, 2029 | $28.23 | $28.23 | $32.49 | +13,215% |
| October, 2029 | $20.83 | $20.83 | $26.73 | +9,724% |
| November, 2029 | $14.84 | $14.85 | $19.31 | +6,901% |
| December, 2029 | $7.4279 | $7.4285 | $13.34 | +3,404% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2030
Theriva Biologics Inc Stock (TOVX) is expected to reach an average price of $184.84 in 2030, with a high forecast of $368.18 and a low forecast of $1.4878. This signifies an +87,086% surge from the last price of $0.212.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4876 | $1.4878 | $5.928 | +601.69% |
| February, 2030 | $128.28 | $153.28 | $230.96 | +60,409% |
| March, 2030 | $222.56 | $156.55 | $191.44 | +104.88K% |
| April, 2030 | $164.00 | $214.00 | $196.26 | +77,258% |
| May, 2030 | $173.97 | $167.27 | $155.35 | +81,962% |
| June, 2030 | $190.20 | $171.30 | $152.87 | +89,615% |
| July, 2030 | $178.32 | $171.74 | $156.57 | +84,012% |
| August, 2030 | $198.42 | $194.30 | $169.37 | +93,492% |
| September, 2030 | $250.41 | $203.57 | $242.91 | +118.02K% |
| October, 2030 | $236.64 | $252.26 | $249.61 | +111.52K% |
| November, 2030 | $252.80 | $230.69 | $243.48 | +119.14K% |
| December, 2030 | $367.99 | $262.53 | $368.18 | +173.48K% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):